ArticleOncoTargets and therapy2020

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.

Liwen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.